The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
AUTOR(ES)
Snow, B J
RESUMO
Movement disorders, including Parkinsonism, are prominent features of neurological Wilson's disease (WD). This suggests there may be dysfunction of the nigrostriatal dopaminergic pathway. To explore this possibility, five patients were studied using positron emission tomography (PET) with 18F-6-fluorodopa (6FD), and magnetic resonance imaging (MRI). We calculated striatal 6FD uptake rate constants by a graphical method and compared the results with those of 18 normal subjects. It was found that four patients with symptoms all had abnormally low 6FD uptake, and the one asymptomatic patient had normal uptake. PET evidence for nigrostriatal dopaminergic dysfunction was present even after many years of penicillamine treatment. It is concluded that the nigrostriatal dopaminergic pathway is involved in neurological WD.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1014291Documentos Relacionados
- Progressive degeneration of the right temporal lobe studied with positron emission tomography.
- Mapping memory with positron emission tomography.
- The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
- Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
- Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.
